CVS Health's strategic pharmacy changes within Target stores. Closures from Feb to Apr due to market dynamics. Prescription transfers to nearby CVS locations.
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Novartis AG (NYSE: NVS) has decided to step back from pursuing the Cytokinetics Inc (NASDAQ: CYTK) acquisition, dealing a blow to the potential deal with the
Endo International (OTC: ENDPQ) has gained approval from U.S. Bankruptcy Court Judge James Garrity to initiate the solicitation of votes for its restructuring plan.
Join the fight against Nipah virus! Oxford Vaccine Group launches groundbreaking ChAdOx1 NipahB vaccine trial, targeting the deadly virus. 51 participants aged 18-55. Funded by CEPI. Help combat Nipah and be part of a vital initiative.
FDA collaborates with Laboratoires Delbert to address syphilis treatment shortage. Learn about the temporary import of Extencilline, an alternative to Bicillin. Shortage expected until June.
AbbVie Inc's (NYSE: ABBV) unwavering confidence in Botox's resilience within the aesthetics market with a commanding 68% market share remains steadfast. Despite a recent FDA petition addressing potential risks, AbbVie emphasizes its commitment to safety with existing 'black box' warnings. Amidst economic uncertainties and emerging competitors, AbbVie anticipates continued strength.
Wednesday, Aclaris Therapeutics Inc (NASDAQ: ACRS) released topline results from its Phase 2b study of ATI-1777, an investigational topical "soft" JAK 1/3 inhibitor, in patients with mild to